Intrafamilial diversity of phenotype associated with app duplication

Neurology

Volumn 71, Issue 23, 2008, Pages 1925-1926

  Guyant Marechal, I ^a,b   Berger, E ^c   Laquerriere A ^a   Rovelet Lecrux, A ^b   Viennet, G ^c   Frebourg, T ^b   Rumbach, L ^c   Campion, D ^b   Hannequin, D ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; DIFFUSE LEWY BODY DISEASE; FEMALE; GENE DUPLICATION; GENE LOCUS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; TREMOR; ALZHEIMER DISEASE; FAMILY HEALTH; GENETICS; MALE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR AMYLOIDOSIS;

AMYLOID PRECURSOR PROTEIN; DESMUSLIN; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CEREBRAL AMYLOID ANGIOPATHY; FAMILY HEALTH; GENE DUPLICATION; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LEWY BODY DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; TAU PROTEINS;

EID: 63849331457     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000339400.64213.56     Document Type: Article

References (7)

1. Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006;38:24-26.
2. Sleegers K, Brouwers N, Gijselinck I, et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 2006;129:2977-2983.
3. Rovelet-Lecrux A, Frebourg T, Tuominen H, Majamaa K, Campion D, Remes AM. APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 2007;78:1158-1159.
4. Menendez M. Down syndrome, Alzheimer's disease and seizures Brain Dev 2005;27:246-252.
5. Leverenz JB, Fishel MA, Peskind ER, et al. Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006;63:370-376.
6. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 1999;45:353-357.
7. Masliah E, Rockenstein E, Veinbergs I, et al. Beta-amyloid peptides enhance alpha-synuclein accumulation and neu-ronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 2001;98:12245-12250.